TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Novartis Norge AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 1,462,548 | 1,307,252 | 1,220,948 |
Financial expenses | 2,396 | 1,334 | 1,608 |
Earnings before taxes | 54,514 | 38,899 | 38,103 |
Total assets | 511,953 | 408,023 | 427,395 |
Current assets | 508,751 | 403,972 | 423,245 |
Current liabilities | 307,622 | 250,569 | 302,160 |
Equity capital | 151,053 | 105,939 | 74,903 |
- share capital | 1,587 | 1,537 | 1,501 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 29.5% | 26.0% | 17.5% |
Turnover per employee | |||
Profit as a percentage of turnover | 3.7% | 3.0% | 3.1% |
Return on assets (ROA) | 11.1% | 9.9% | 9.3% |
Current ratio | 165.4% | 161.2% | 140.1% |
Return on equity (ROE) | 36.1% | 36.7% | 50.9% |
Change turnover | 112,667 | 57,612 | -292,475 |
Change turnover % | 8% | 5% | -19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.